Foundayo
Entity.
- Evidence
- 27 documents · 16 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 6 Apr 2026, last seen 3 Oct 2026
- Measured
- 26% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- Medical Daily · 2026-10-03 · Rhode Island Medicaid Ends Coverage of Wegovy, Zepbound, and Other GLP-1 Drugs Prescribed Only for Weight Loss (opens the source in a new tab)
- European Medical Journal · 2026-10-03 · Forghorn slashes workforce by 40% after deal with Eli Lilly ends (opens the source in a new tab)
- Fierce Pharma · 2026-10-01 · Lilly gives deeper glimpse at Foundayo's heart-helping odds in diabetes, obesity phase 3 (opens the source in a new tab)
- Chemical & Engineering News · 2026-10-01 · Weight-loss-drug makers unveil new data and deals (opens the source in a new tab)
- Fierce Pharma · 2026-09-30 · Novo, Lilly pit their GLP-1s against one another in diabetes and obesity as EASD kicks off in Milan (opens the source in a new tab)
- Clinical Trials Arena · 2026-09-30 · Lilly reports comparative data from ACHIEVE-3 and PIONEER PLUS studies (opens the source in a new tab)
- Fierce Pharma · 2026-09-29 · Eli Lilly's new initiative will take GLP-1s to lower-income nations (opens the source in a new tab)
- PR Daily · 2026-09-28 · The Scoop: Eli Lilly defends presence at Vogue World (opens the source in a new tab)
- 24/7 Wall St. · 2026-09-28 · Eli Lilly Wavered Over the Last Month: One of Wall Street’s Biggest Banks Says 35% Gains Still to Come (opens the source in a new tab)
- The Guardian · 2026-09-27 · ‘It’s problematic’: concern as weight-loss jab maker sponsors Vogue World event (opens the source in a new tab)
- Fierce Pharma · 2026-09-26 · Eli Lilly blasted for ‘promotional and emotive’ language in GLP-1 press release (opens the source in a new tab)